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Abstract 
【Background】  
Glucocorticoids are popular anti-inflammatory drug, on the other hand, the strong immunomodulatory 
effect causes undesirable effects including osteonecrosis of the femoral head (ONFH). Mesenchymal stem 
cells (MSCs) are considered as promising cells to treat ONFH due to their multi-differentiation potential 
and the ability to produce cytokines that recruit various types of cells for tissue regeneration. However, the 
effect of glucocorticoid therapy on MSCs has not been fully elucidated yet. The present study aimed to 
investigate the effect of glucocorticoids on the function of bone regeneration in MSCs. Moreover, I aimed 
to characterize the function of MSCs derived from steroid-induced ONFH patients who received high-dose 
and long-period glucocorticoid therapy and elucidated the underlying molecular mechanism. 
 
【Results】  
1) BM-MSCs derived from steroidal ONFH patients have less proliferative and self-renewal ability 
compared with BM-MSCs derived from traumatic ONFH patients 
To clarify the effect of glucocorticoid on the character of bone marrow-derived MSCs (BM-MSCs), colony 
formation assay using primary bone marrow aspirate from traumatic or steroid-induced ONFH patients 
was performed, and I found bone marrow derived from steroid-induced ONFH patients contained less 
number of BM-MSCs than traumatic ONFH patients. In addition, BM-MSCs derived from steroid-induced 
ONFH patients (sBM-MSCs) showed less and unstable proliferative ability compared with BM-MSCs 
derived from traumatic ONFH patients.  
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2) The osteogenic potential of AT-MSCs derived from steroidal ONFH patients are impaired by inhibition 
of wnt/β-catenin signaling 
In order to investigate the differences in the characteristics between bone marrow and adipose tissue, I next 
isolated and analyzed adipose tissue derived MSCs from steroid-induced ONFH patients (sAT-MSC). 
Their proliferative potential was not impaired; however, the osteogenic potential of sAT-MSCs was 
decreased compared with AT-MSCs derived from traumatic ONFH patients (nAT-MSC). Therefore, I 
investigated the expression of osteogenic genes and alkaline phosphatase (ALP), which regulated the 
calcification of extracellular matrix, was downregulated in sAT-MSCs during osteogenesis. To confirm 
whether ALP is responsible for the impairment of osteogenesis in sAT-MSCs, ALP-overexpressing 
sAT-MSCs were established and overexpression of ALP recovered the impaired osteogenic ability in 
sAT-MSCs.  
To identify the downregulation mechanism of ALP in sAT-MSCs, I focused on wnt/β-catenin signaling 
that plays an important role in bone development. I found that Dickkopf1 (Dkk-1), one of the known 
antagonists of wnt/βcatenin signaling, was upregulated in sAT-MSCs, where, in this situation, the impaired 
osteogenic potential was rescued when Dkk-1 shRNA (shDkk-1) was transfected. Consistent with these 
results, nAT-MSCs chronically exposed to dexamethasone in vitro, which mimicked the microenvironment 
of sAT-MSCs, also showed reduced osteogenic differentiation ability and increased expression of Dkk-1 
that downregulated ALP. 
 
3) Lowered bone regeneration capacity of sAT-MSCs is reversed by shDkk1 
The abnormal expression of osteogenesis-related factors in sAT-MSCs suggested that sAT-MSCs might 
have less bone regenerative capacity than nAT- MSCs, possibly because of the overexpression of Dkk-1. 
Therefore, I examined the bone regenerative capacity of nAT-MSCs, sAT-MSCs, nAT-MSCs transfected 
with mock, sAT-MSCs transfected with mock, and sAT-MSCs transfected with shDkk-1, using the 
critical-sized calvarial defect mouse model. nAT-MSCs and mock-transfected nAT-MSCs could facilitate 
bone formation, whereas sAT-MSCs showed impaired bone regenerative capacity. In contrast, 
shDkk-1-transfected sAT-MSCs showed significant increases in bone regenerative capacity compared with 
the sAT-MSCs transfected with mock. To prove the presence of transplanted AT-MSCs in the repaired 
bone regions, I performed immunohistological analysis using anti-human osteipontin (hOPN) antibody, 
which is a maker of mature osteoblast, and found there were hOPN-positive cells in the repaired bone 
region with nAT-MSCs, mock-transfected nAT-MSCs and shDkk-1-transfected sAT-MSCs. On the other 
hand, no positive cells were observed in sAT-MSCs and mock-transfected sAT-MSCs at the transplanted 
regions. Of note, plasma Dkk-1 levels were elevated in steroid-induced ONFH patients.  
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【Discussion】  
In the present study, I demonstrated that chronic glucocorticoid treatment impaired the proliferative 
potential of BM-MSCs whereas proliferation in AT-MSCs derived from steroid-induced ONFH was not 
affected. On the other hand, the osteogenic ability of sAT-MSCs was impaired through the downregulation 
of wnt/β-catenin signaling due to highly expressed Dkk-1. Interestingly, the elevated level of Dkk-1 was 
also observed in the plasma from steroid-induced ONFH patients. These results suggested Dkk-1 
expression would be the key promoter of AT-MSCs as a useful therapy source.  
 
